Wednesday, 16 August 2017

Generics News

  • German firm buys $200 mn stake in Indian generic company

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 28 Nov, 2013

    Singapore: Gland Pharma, a leading Indian pure-play generic injectable pharmaceutical products company, has signed an agreement under which KKR, a global investment firm, will acquire a min...Read more

  • Biocon: A nesting ground for biotech spinoffs

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment | 16 May, 2014

    It has added one more feather to its cap by being the nesting ground to churn out new start-ups. It is an informal incubation lab for new spinoffs. Biocon, without any hesitance, is the mo...Read more

  • FAPA: Indian pharma to fatten in biosimilars era

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2014

    Singapore: The Federation of Asian Pharmaceuticals Association (FAPA) said that the upcoming patent cliff will be advantageous for the Indian drug makers as biosimilars are all set to make ...Read more

  • Celltrion files an FDA application for biosimilar

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2014

    Singapore: With biosimilars promising an exponential growth, South Korea's Celltrion has filed an FDA application for Remisma, a biosilmilar of Johnson & Johnson's (J&J) blockbuster...Read more

  • Wockhardt's third Indian plant faces export ban

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2013

    Singapore: Britain's drug regulator, the UK Medicines and Healthcare Products Regulatory Agency has revoked the quality compliance certificate provided to Wockhardt's third unit in India. ...Read more

  • Cipla appoints Subhanu Saxena as CEO

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 23 Nov, 2012

    Mumbai: Indian generic pharmaceuticals company Cipla appointed Mr Subhanu Saxena as its chief executive officer. Mr Saxena comes to Cipla with experience of over 25 years, having worked wit...Read more

  • Cipla divests its stake from a Chinese firm

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2014

    Singapore: Indian pharma major, Cipla recently announced that the company's wholly owned subsidiary Meditab holdings entered into a definitive agreement to sell its entire 48.22 per cent st...Read more

  • Lupin, LG to launch an anti-diabetes drug

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2014

    Singapore: Indian drug major Lupin has inked a marketing pact with South Korea's LG Life Sciences to launch its anti-diabetes drug in India. As per the strategic distribution pact inked b...Read more

  • GSK to appoint RBS exec as new chairman

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 11 Aug, 2014

    Singapore: British drug maker GlaxoSmithKline is in advanced talks to recruit Sir Philip Hampton, chairman of Royal Bank of Scotland, as the next chairman. According to Sky News report, Sir...Read more

  • Cipla's HIV drug gets tentative nod from FDA

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 27 Feb, 2014

    Singapore: India based generic drug maker Cipla has recieved FDA tentative approval for a generic formulation of emtricitabine and tenofovir disoproxil fumarate tablets, 200 mg/300 mg. The...Read more

  • Dr. Reddy's Azacitidine for injection gets FDA nod

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013

    Singapore: The US FDA has granted approval for the launch of Dr. Reddy's Laboratories's cancer drug Azacitidine for injection. This generic version of Vidaza is used in the treatment of mye...Read more

  • Aurobindo aims for $2 bn revenues by FY15

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2014

    Singapore: India-based Aurobindo Pharma eyes on globalization and innovation to achieve a turnover of $2 billion in the current fiscal year. With 45 files under review with the USFDA, the ...Read more

  • Alvogen acquires Korea's Dream Pharma

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2014

    Singapore: The birth of one of the largest generic pharmaceutical companies in South Korea just came about when Alvogen decided to acquire Korea's Dream Pharma. The deal, closed in cash, in...Read more

  • Aurobindo gets FDA nod for anti-depression generic

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2012

    Singapore: India's Aurobindo Pharma received final approval from the US FDA to manufacture and market Escitalopram Oxalate tablets 5mg, 10mg and 20mg (ANDA 090432), which was earlier tentat...Read more

  • Canada quarantines APIs by India firm

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2015

    Singapore: Canada has quarantined the health products made with active pharmaceutical ingredients (APIs) from India's Sri Krishna Pharmaceuticals due to data integrity concerns. Health Can...Read more

  • Fosun Pharma listed in CCTV Financial 50 Index Sample Stock

    Generics |  Company results | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2013

    Singapore: Shanghai Fosun Pharmaceutical has been listed in CCTV Financial 50 Index Sample Stock, an index created by Shenzhen Securities Information and CCTV Finance Channel with the index...Read more

  • First generic of diabetes drug Actos approved

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 20 Aug, 2012

    Singapore: The US FDA has approved world's first generic version of Actos (pioglitazone hydrochloride) tablets. US-based pharma company Mylan Pharmaceuticals, received FDA approval for 15 m...Read more

  • Ranbaxy redesigns strategy to meet regulations

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2012

    The year 2011 was a year of capturing potential markets and achieving new milestones. Ranbaxy Laboratories became the first pharmaceutical company of Indian origin to cross a figure of $1.5...Read more

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls